233 related articles for article (PubMed ID: 17272811)
1. Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop.
Yan C; Ding B; Shishido T; Woo CH; Itoh S; Jeon KI; Liu W; Xu H; McClain C; Molina CA; Blaxall BC; Abe J
Circ Res; 2007 Mar; 100(4):510-9. PubMed ID: 17272811
[TBL] [Abstract][Full Text] [Related]
2. A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis.
Ding B; Abe J; Wei H; Xu H; Che W; Aizawa T; Liu W; Molina CA; Sadoshima J; Blaxall BC; Berk BC; Yan C
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14771-6. PubMed ID: 16186489
[TBL] [Abstract][Full Text] [Related]
3. Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure.
Ding B; Abe JI; Wei H; Huang Q; Walsh RA; Molina CA; Zhao A; Sadoshima J; Blaxall BC; Berk BC; Yan C
Circulation; 2005 May; 111(19):2469-2476. PubMed ID: 15867171
[TBL] [Abstract][Full Text] [Related]
4. Novel role of C terminus of Hsc70-interacting protein (CHIP) ubiquitin ligase on inhibiting cardiac apoptosis and dysfunction via regulating ERK5-mediated degradation of inducible cAMP early repressor.
Woo CH; Le NT; Shishido T; Chang E; Lee H; Heo KS; Mickelsen DM; Lu Y; McClain C; Spangenberg T; Yan C; Molina CA; Yang J; Patterson C; Abe J
FASEB J; 2010 Dec; 24(12):4917-28. PubMed ID: 20724525
[TBL] [Abstract][Full Text] [Related]
5. Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart.
Yan C; Miller CL; Abe J
Circ Res; 2007 Mar; 100(4):489-501. PubMed ID: 17332439
[TBL] [Abstract][Full Text] [Related]
6. p90RSK targets the ERK5-CHIP ubiquitin E3 ligase activity in diabetic hearts and promotes cardiac apoptosis and dysfunction.
Le NT; Takei Y; Shishido T; Woo CH; Chang E; Heo KS; Lee H; Lu Y; Morrell C; Oikawa M; McClain C; Wang X; Tournier C; Molina CA; Taunton J; Yan C; Fujiwara K; Patterson C; Yang J; Abe J
Circ Res; 2012 Feb; 110(4):536-50. PubMed ID: 22267842
[TBL] [Abstract][Full Text] [Related]
7. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury.
Oikawa M; Wu M; Lim S; Knight WE; Miller CL; Cai Y; Lu Y; Blaxall BC; Takeishi Y; Abe J; Yan C
J Mol Cell Cardiol; 2013 Nov; 64():11-9. PubMed ID: 23988739
[TBL] [Abstract][Full Text] [Related]
9. Interventional effect of valsartan on expression of inducible cAMP early repressor and phosphodiesterase 3A in rats after myocardial infarction.
Ma D; Fu L; Shen J; Zhou P; Gao Y; Xie R; Li Y; Han Y; Wang Y; Wang F
Eur J Pharmacol; 2009 Jan; 602(2-3):348-54. PubMed ID: 19027736
[TBL] [Abstract][Full Text] [Related]
10. Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice.
Sun B; Li H; Shakur Y; Hensley J; Hockman S; Kambayashi J; Manganiello VC; Liu Y
Cell Signal; 2007 Aug; 19(8):1765-71. PubMed ID: 17482796
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias.
Lehnart SE; Wehrens XH; Reiken S; Warrier S; Belevych AE; Harvey RD; Richter W; Jin SL; Conti M; Marks AR
Cell; 2005 Oct; 123(1):25-35. PubMed ID: 16213210
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP.
Liu H; Maurice DH
Br J Pharmacol; 1998 Dec; 125(7):1501-10. PubMed ID: 9884079
[TBL] [Abstract][Full Text] [Related]
13. Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B.
Zhang W; Ke H; Tretiakova AP; Jameson B; Colman RW
Protein Sci; 2001 Aug; 10(8):1481-9. PubMed ID: 11468344
[TBL] [Abstract][Full Text] [Related]
14. Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart.
Kimura TE; Jin J; Zi M; Prehar S; Liu W; Oceandy D; Abe J; Neyses L; Weston AH; Cartwright EJ; Wang X
Circ Res; 2010 Mar; 106(5):961-70. PubMed ID: 20075332
[TBL] [Abstract][Full Text] [Related]
15. Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction.
Shishido T; Woo CH; Ding B; McClain C; Molina CA; Yan C; Yang J; Abe J
Circ Res; 2008 Jun; 102(11):1416-25. PubMed ID: 18467627
[TBL] [Abstract][Full Text] [Related]
16. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
[TBL] [Abstract][Full Text] [Related]
17. Isoforms of cyclic nucleotide phosphodiesterase PDE3A in cardiac myocytes.
Wechsler J; Choi YH; Krall J; Ahmad F; Manganiello VC; Movsesian MA
J Biol Chem; 2002 Oct; 277(41):38072-8. PubMed ID: 12154085
[TBL] [Abstract][Full Text] [Related]
18. Rolipram, a phosphodiesterase 4 inhibitor, stimulates inducible cAMP early repressor expression in osteoblasts.
Cho ES; Yu JH; Kim MS; Yim M
Yonsei Med J; 2005 Feb; 46(1):149-54. PubMed ID: 15744818
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase B/Akt phosphorylation of PDE3A and its role in mammalian oocyte maturation.
Han SJ; Vaccari S; Nedachi T; Andersen CB; Kovacina KS; Roth RA; Conti M
EMBO J; 2006 Dec; 25(24):5716-25. PubMed ID: 17124499
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
Murray F; MacLean MR; Pyne NJ
Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
